Literature DB >> 16868018

Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis.

Shailaja S Bhatia1, Darcy S Majka, John M Kittelson, Lezlie A Parrish, Elizabeth D Ferucci, Kevin D Deane, William P Arend, Marian Rewers, V Michael Holers, Jill M Norris.   

Abstract

OBJECTIVES: To examine whether oral contraceptive use is associated with the presence of serum rheumatoid factor in women of reproductive age without rheumatoid arthritis.
METHODS: 304 women selected from parents of children who were at increased risk of developing type 1 diabetes were studied, because they were enriched with the human leucocyte antigen-DR4 allele, a susceptibility marker for both type 1 diabetes and rheumatoid arthritis. Participants visited a clinic where blood was drawn for rheumatoid factor testing, and exposure data were collected via questionnaires. A medical history and joint examination were performed to rule out rheumatoid arthritis. Participants and examiners were unaware of the participants' rheumatoid factor status at the time of examination and questionnaire.
RESULTS: Use of oral contraceptives at any time was inversely associated with rheumatoid factor positivity (adjusted odds ratio (OR) 0.2, 95% confidence interval (CI) 0.07 to 0.52) independent of age, education and smoking. Smoking > or = 20 pack-years was also associated with rheumatoid factor positivity (adjusted OR 56.38, 95% CI 4.31 to 736.98) compared with never smoking. Smoking 1-19 pack-years was not associated with a positive rheumatoid factor.
CONCLUSIONS: Our results suggest that oral contraceptive use, and possibly cigarette smoking, act early in the development of the immune dysregulation that occurs in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868018      PMCID: PMC1798510          DOI: 10.1136/ard.2006.060004

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity.

Authors:  M Pladevall-Vila; G L Delclos; C Varas; H Guyer; J Brugués-Tarradellas; A Anglada-Arisa
Journal:  Am J Epidemiol       Date:  1996-07-01       Impact factor: 4.897

2.  Association of autoantibodies with smoking, cardiovascular morbidity, and death in the Busselton population.

Authors:  J D Mathews; S Whittingham; B M Hooper; I R Mackay; N S Stenhouse
Journal:  Lancet       Date:  1973-10-06       Impact factor: 79.321

3.  Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.

Authors:  C Jorgensen; M C Picot; C Bologna; J Sany
Journal:  Ann Rheum Dis       Date:  1996-02       Impact factor: 19.103

4.  A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor.

Authors:  H D Halldórsdóttir; T Jónsson; J Thorsteinsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

5.  Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis.

Authors:  B Masdottir; T Jónsson; V Manfredsdottir ; A Víkingsson; A Brekkan; H Valdimarsson
Journal:  Rheumatology (Oxford)       Date:  2000-11       Impact factor: 7.580

6.  The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis.

Authors:  T D Spector; M C Hochberg
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

7.  Smoking and risk of rheumatoid arthritis.

Authors:  M Heliövaara; K Aho; A Aromaa; P Knekt; A Reunanen
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

8.  Does smoking stimulate rheumatoid factor production in non-rheumatic individuals?

Authors:  T Jónsson; J Thorsteinsson; H Valdimarsson
Journal:  APMIS       Date:  1998-10       Impact factor: 3.205

9.  The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study.

Authors:  Michele F Doran; Cynthia S Crowson; W Michael O'Fallon; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

Review 10.  Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.

Authors:  P Stolt; C Bengtsson; B Nordmark; S Lindblad; I Lundberg; L Klareskog; L Alfredsson
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

View more
  19 in total

Review 1.  Environmental and gene-environment interactions and risk of rheumatoid arthritis.

Authors:  Elizabeth W Karlson; Kevin Deane
Journal:  Rheum Dis Clin North Am       Date:  2012-05-30       Impact factor: 2.670

2.  Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.

Authors:  Ted R Mikuls; Geoffrey M Thiele; Kevin D Deane; Jeffrey B Payne; James R O'Dell; Fang Yu; Harlan Sayles; Michael H Weisman; Peter K Gregersen; Jane H Buckner; Richard M Keating; Lezlie A Derber; William H Robinson; V Michael Holers; Jill M Norris
Journal:  Arthritis Rheum       Date:  2012-11

Review 3.  Genetic and environmental risk factors for rheumatoid arthritis.

Authors:  Kevin D Deane; M Kristen Demoruelle; Lindsay B Kelmenson; Kristine A Kuhn; Jill M Norris; V Michael Holers
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-09-18       Impact factor: 4.098

Review 4.  Insights from populations at risk for the future development of classified rheumatoid arthritis.

Authors:  V Michael Holers
Journal:  Rheum Dis Clin North Am       Date:  2014-09-06       Impact factor: 2.670

Review 5.  Can rheumatoid arthritis be prevented?

Authors:  Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-10-02       Impact factor: 4.098

6.  A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA.

Authors:  Jason R Kolfenbach; Kevin D Deane; Lezlie A Derber; Colin O'Donnell; Michael H Weisman; Jane H Buckner; Vivian H Gersuk; Shan Wei; Ted R Mikuls; James O'Dell; Peter K Gregersen; Richard M Keating; Jill M Norris; V Michael Holers
Journal:  Arthritis Rheum       Date:  2009-12-15

Review 7.  The Roles of Cigarette Smoking and the Lung in the Transitions Between Phases of Preclinical Rheumatoid Arthritis.

Authors:  Jeffrey A Sparks; Elizabeth W Karlson
Journal:  Curr Rheumatol Rep       Date:  2016-03       Impact factor: 4.592

Review 8.  Strategies to predict rheumatoid arthritis development in at-risk populations.

Authors:  Elizabeth W Karlson; Dirkjan van Schaardenburg; Annette H van der Helm-van Mil
Journal:  Rheumatology (Oxford)       Date:  2014-08-04       Impact factor: 7.580

9.  Plasma 25,OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA.

Authors:  Marie Feser; Lezlie A Derber; Kevin D Deane; Dennis C Lezotte; Michael H Weisman; Jane H Buckner; Ted Mikuls; James O'Dell; Peter K Gregersen; V Michael Holers; Jill M Norris
Journal:  J Rheumatol       Date:  2009-03-13       Impact factor: 4.666

Review 10.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Authors:  Kevin D Deane; Hani El-Gabalawy
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.